1. Home
  2. ESEA vs DNA Comparison

ESEA vs DNA Comparison

Compare ESEA & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Euroseas Ltd. (Marshall Islands)

ESEA

Euroseas Ltd. (Marshall Islands)

HOLD

Current Price

$66.11

Market Cap

481.2M

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.13

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESEA
DNA
Founded
2005
2008
Country
Greece
United States
Employees
N/A
485
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.2M
455.8M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ESEA
DNA
Price
$66.11
$9.13
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$62.00
$8.50
AVG Volume (30 Days)
73.0K
1.2M
Earning Date
06-17-2026
05-07-2026
Dividend Yield
4.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.74
N/A
Revenue Next Year
$1.07
N/A
P/E Ratio
$3.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$43.60
$5.37
52 Week High
$78.76
$17.58

Technical Indicators

Market Signals
Indicator
ESEA
DNA
Relative Strength Index (RSI) 51.06 59.00
Support Level $66.29 $7.59
Resistance Level $71.86 $10.27
Average True Range (ATR) 2.69 0.74
MACD 0.39 0.01
Stochastic Oscillator 53.44 53.10

Price Performance

Historical Comparison
ESEA
DNA

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: